Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00351676|
Recruitment Status : Completed
First Posted : July 13, 2006
Last Update Posted : December 11, 2007
|Condition or disease||Intervention/treatment||Phase|
|Heart Failure, Congestive Pulmonary Disease, Chronic Obstructive Pneumonia Diabetes Mellitus, Type 2 Coronary Arteriosclerosis||Behavioral: Integration of a team based clinical pharmacist Drug: Optimizing therapeutic treatments Behavioral: Optimizing processes of care||Phase 4|
The overall goal of the COLLABORATE study is to improve processes of care and patient outcomes by optimizing drug therapy via a hospital pharmacy practice model that integrates clinical pharmacists into the patient care team.
The intervention consists of a clinical pharmacist assigned to the patient care team for the purpose of providing proactive clinical pharmacy services. The study pharmacist will be available during normal office hours 5 days per week to provide clarification of the patient's medication history, identify and resolve actual and potential patient specific drug related problems/issues, participate in patient care rounds, provide drug information to the patient care team, provide patient education and discharge medication counselling, and provide physician and/or nursing staff education. The anticipated pharmacist to patient ratio is approximately 1:20.
Control patients will receive usual care. Usual care consists of reactive clinical pharmacy services (i.e. drug related issues identified as orders are received, or by patient profile review) provided by a ward based, not team based, clinical pharmacist.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||452 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment (COLLABORATE)|
|Study Start Date :||February 2006|
|Actual Study Completion Date :||July 2007|
- Improvement in proportion of quality indicators achieved, for target diseases as a most responsible or primary diagnosis, between groups. [ Time Frame: in hospital ]
- Differences in condition-specific achievement of drug therapy quality indicators; [ Time Frame: in hospital ]
- Differences in 6 month hospital readmission rate; [ Time Frame: 6 months ]
- Differences in number, type, acceptance rate, and expected impact of all pharmacist interventions; [ Time Frame: in hospital ]
- Qualitative evaluation of the impact of the intervention via interviews with the participating pharmacists and physicians. [ Time Frame: in hospital ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00351676
|Royal Alexandra Hospital|
|Edmonton, Alberta, Canada, T5H 3V9|
|University of Alberta Hospital|
|Edmonton, Alberta, Canada, T6G 2B7|
|Grey Nuns Community Hospital|
|Edmonton, Alberta, Canada, T6L 5X8|
|Principal Investigator:||Ross T. Tsuyuki, PharmD, MSc||University of Alberta|